Trastuzumab: What It Is, How It Works, and What You Need to Know

When you hear trastuzumab, a targeted monoclonal antibody used to treat certain types of breast cancer. Also known as Herceptin, it doesn't work like traditional chemo—it goes straight for cancer cells that overproduce the HER2 protein. This makes it one of the most precise tools doctors have for HER2-positive breast cancer, a subtype that grows faster and was once harder to treat. Before trastuzumab, survival rates for this type of cancer were lower. Now, it’s a cornerstone of treatment for many patients, often used alongside chemo or after surgery to reduce the chance of return.

Trastuzumab belongs to a class called monoclonal antibodies, laboratory-made proteins designed to mimic the immune system’s ability to fight harmful cells. Unlike chemo that attacks all fast-growing cells, trastuzumab locks onto HER2 receptors on cancer cells, blocking signals that tell them to grow and multiply. It also flags those cells for destruction by your own immune system. This precision is why side effects are often different—less hair loss, but potential heart issues. That’s why doctors monitor heart function before and during treatment. It’s not a cure-all, but for the right patients, it changes outcomes.

People taking trastuzumab often need to manage other medications at the same time. You might be on chemotherapy, drugs like paclitaxel or docetaxel that are commonly combined with trastuzumab to boost effectiveness, or dealing with side effects like fatigue, fever, or nausea. Some patients worry about long-term heart health, and rightly so—studies show a small but real risk of reduced heart function. That’s why tracking drug safety, understanding dosing schedules, and knowing when to call your doctor matters. You’re not just taking a pill—you’re managing a treatment plan that requires attention to detail, especially when traveling or dealing with other health conditions.

What you’ll find below are real, practical guides written for people navigating this journey. From how to handle missed doses of trastuzumab to understanding how it interacts with other drugs, how to recognize warning signs, and what to ask your oncologist. You’ll see how it fits into broader cancer care—like managing side effects, staying safe during treatment, and making sense of lab results. These aren’t theory pieces. They’re tools made by people who’ve been there, asking the same questions you are.

HER2-Positive Breast Cancer: Targeted Therapies Explained
25 Nov

HER2-positive breast cancer is now highly treatable thanks to targeted therapies like trastuzumab, T-DXd, and tucatinib. Learn how these drugs work, their side effects, and why survival rates have improved dramatically.